These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 24715245)
1. Inverse prognostic impact of ErbB2 mRNA and protein expression level in tumors of soft tissue sarcoma patients. Wichmann H; Güttler A; Bache M; Taubert H; Vetter M; Würl P; Holzhausen HJ; Eckert AW; Kappler M; Vordermark D Strahlenther Onkol; 2014 Oct; 190(10):912-8. PubMed ID: 24715245 [TBL] [Abstract][Full Text] [Related]
2. Low HIF-1α and low EGFR mRNA Expression Significantly Associate with Poor Survival in Soft Tissue Sarcoma Patients; the Proteins React Differently. Rot S; Taubert H; Bache M; Greither T; Würl P; Holzhausen HJ; Eckert AW; Vordermark D; Kappler M Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30513863 [TBL] [Abstract][Full Text] [Related]
3. High coexpression of CCL2 and CX3CL1 is gender-specifically associated with good prognosis in soft tissue sarcoma patients. Kehlen A; Greither T; Wach S; Nolte E; Kappler M; Bache M; Holzhausen HJ; Lautenschläger C; Göbel S; Würl P; Immel UD; Agaimy A; Wullich B; Taubert H Int J Cancer; 2014 Nov; 135(9):2096-106. PubMed ID: 24676787 [TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of mRNA levels of osteopontin splice variants in soft tissue sarcoma patients. Hahnel A; Wichmann H; Greither T; Kappler M; Würl P; Kotzsch M; Taubert H; Vordermark D; Bache M BMC Cancer; 2012 Apr; 12():131. PubMed ID: 22471890 [TBL] [Abstract][Full Text] [Related]
5. Elevated tumor and serum levels of the hypoxia-associated protein osteopontin are associated with prognosis for soft tissue sarcoma patients. Bache M; Kappler M; Wichmann H; Rot S; Hahnel A; Greither T; Said HM; Kotzsch M; Würl P; Taubert H; Vordermark D BMC Cancer; 2010 Apr; 10():132. PubMed ID: 20377868 [TBL] [Abstract][Full Text] [Related]
6. A novel splice variant of the stem cell marker LGR5/GPR49 is correlated with the risk of tumor-related death in soft-tissue sarcoma patients. Rot S; Taubert H; Bache M; Greither T; Würl P; Eckert AW; Schubert J; Vordermark D; Kappler M BMC Cancer; 2011 Oct; 11():429. PubMed ID: 21978106 [TBL] [Abstract][Full Text] [Related]
7. ErbB2, ErbB3 and ErbB4 expression in urothelial tumors of the upper urinary tract and their prognostic significance. Galanakis I; Spyropoulos E; Gkialas I; Nomikos A; Souka E; Mitropoulos D J BUON; 2013; 18(3):653-9. PubMed ID: 24065479 [TBL] [Abstract][Full Text] [Related]
8. Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab. Kurebayashi J; Kanomata N; Yamashita T; Shimo T; Mizutoh A; Moriya T; Sonoo H Breast Cancer; 2015 May; 22(3):292-9. PubMed ID: 23749689 [TBL] [Abstract][Full Text] [Related]
9. Expression of HER2/neu does not correlate with survival in soft tissue sarcoma. Sato T; Peiper M; Heinecke A; Zurakowski D; Eisenberger CF; Hosch S; Knoefel WT; Izbicki JR Onkologie; 2003 Jun; 26(3):268-71. PubMed ID: 12845212 [TBL] [Abstract][Full Text] [Related]
10. Benefit of Adjuvant Radiotherapy for Local Control, Distant Metastasis, and Survival Outcomes in Patients with Localized Soft Tissue Sarcoma: Comparative Effectiveness Analysis of an Observational Cohort Study. Posch F; Partl R; Döller C; Riedl JM; Smolle M; Leitner L; Bergovec M; Liegl-Atzwanger B; Stotz M; Bezan A; Gerger A; Pichler M; Kapp KS; Stöger H; Leithner A; Szkandera J Ann Surg Oncol; 2018 Mar; 25(3):776-783. PubMed ID: 28895087 [TBL] [Abstract][Full Text] [Related]
11. Cytoplasmic maspin expression predicts poor prognosis of patients with soft tissue sarcomas. Takeda C; Takagi Y; Shiomi T; Nosaka K; Yamashita H; Osaki M; Endo K; Minamizaki T; Teshima R; Nagashima H; Umekita Y Diagn Pathol; 2014 Oct; 9():205. PubMed ID: 25358722 [TBL] [Abstract][Full Text] [Related]
12. Expression of epidermal growth factor receptor, ERBB2 and KIT in adult soft tissue sarcomas: a clinicopathologic study of 281 cases. Sato O; Wada T; Kawai A; Yamaguchi U; Makimoto A; Kokai Y; Yamashita T; Chuman H; Beppu Y; Tani Y; Hasegawa T Cancer; 2005 May; 103(9):1881-90. PubMed ID: 15772959 [TBL] [Abstract][Full Text] [Related]
13. Prognostic factors in soft tissue sarcoma. Maretty-Nielsen K Dan Med J; 2014 Nov; 61(11):B4957. PubMed ID: 25370967 [TBL] [Abstract][Full Text] [Related]
14. Prognostic Role of Survivin and Macrophage Infiltration Quantified on Protein and mRNA Level in Molecular Subtypes Determined by RT-qPCR of Ecke TH; Kiani A; Schlomm T; Friedersdorff F; Rabien A; Jung K; Kilic E; Boström P; Tervahartiala M; Taimen P; Gleichenhagen J; Johnen G; Brüning T; Koch S; Roggisch J; Wirtz RM Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33050010 [TBL] [Abstract][Full Text] [Related]
15. Elevated expression level of survivin protein in soft-tissue sarcomas is a strong independent predictor of survival. Kappler M; Kotzsch M; Bartel F; Füssel S; Lautenschläger C; Schmidt U; Würl P; Bache M; Schmidt H; Taubert H; Meye A Clin Cancer Res; 2003 Mar; 9(3):1098-104. PubMed ID: 12631613 [TBL] [Abstract][Full Text] [Related]
16. Prognostic value of ERBB family mRNA expression in breast carcinomas. Bièche I; Onody P; Tozlu S; Driouch K; Vidaud M; Lidereau R Int J Cancer; 2003 Sep; 106(5):758-65. PubMed ID: 12866037 [TBL] [Abstract][Full Text] [Related]
17. The pretreatment erythrocyte sedimentation rate predicts survival outcomes after surgery and adjuvant radiotherapy for extremity soft tissue sarcoma. Park G; Song SY; Ahn JH; Kim WL; Lee JS; Jeong SY; Park JW; Choi EK; Choi W; Jung IH Radiat Oncol; 2019 Jul; 14(1):116. PubMed ID: 31272506 [TBL] [Abstract][Full Text] [Related]
18. The efficacy of postoperative radiotherapy in localized primary soft tissue sarcoma treated with conservative surgery. Zhao RP; Yu XL; Zhang Z; Jia LJ; Feng Y; Yang ZZ; Chen XX; Wang J; Ma SL; Guo XM Radiat Oncol; 2016 Feb; 11():25. PubMed ID: 26911328 [TBL] [Abstract][Full Text] [Related]
19. Prognostic Significance of Thrombomodulin mRNA in High-Grade Soft Tissue Sarcomas after 10 years. Asanuma K; Nakamura T; Asanuma Y; Okamoto T; Kakimoto T; Yada Y; Hagi T; Kita K; Nakamura K; Matsumine A; Sudo A Orthop Surg; 2020 Dec; 12(6):1726-1732. PubMed ID: 33015987 [TBL] [Abstract][Full Text] [Related]
20. Postoperative radiation boost does not improve local recurrence rates in extremity soft tissue sarcomas. Alamanda VK; Song Y; Shinohara E; Schwartz HS; Holt GE J Med Imaging Radiat Oncol; 2014 Oct; 58(5):633-40. PubMed ID: 24821569 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]